Literature DB >> 31169604

Increasing Povidone-Iodine Exposure in Endothelial Keratoplasty Tissue Processing and Fungal Infection Impact.

C Drew Salisbury1, Carter N Kirk2, W Barry Lee1,3, Stephen M Hamilton1, Alan M Kozarsky1,3, Eric Meinecke3, R Doyle Stulting3,4.   

Abstract

PURPOSE: To evaluate the effect on donor rim cultures and postoperative infections of doubling the povidone-iodine exposure time during corneal tissue recovery before its use in keratoplasty.
METHODS: Consecutive donor cornea recoveries were evaluated for positive donor corneal rim cultures and postoperative infections before and after a protocol change of doubling the exposure time of povidone-iodine during donor preparation.
RESULTS: In 631 consecutive cornea donor recoveries, 18 (2.9%) had positive fungal rim cultures and 41 (6.5%) had positive bacterial rim cultures. Three (0.48%) developed postoperative fungal infections, and no bacterial infections occurred. After doubling the povidone-iodine exposure time during the recovery process, 725 consecutive corneas were reviewed. Four (0.6%) had positive fungal rim cultures, and 29 (4.0%) had positive bacterial rim cultures. No postoperative fungal or bacterial infections occurred. No noticeable increase in epithelial toxicity developed between the 2 groups.
CONCLUSIONS: Increasing the povidone-iodine exposure time during the donor cornea recovery process decreased the rate of positive donor corneal rim fungal cultures (P = 0.001), positive donor corneal rim bacterial cultures (P = 0.04), and postoperative fungal infections (P = 0.06).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31169604     DOI: 10.1097/ICO.0000000000002006

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  1 in total

1.  Acute endophthalmitis after penetrating and endothelial keratoplasty at a tertiary eye care center over a 13-year period.

Authors:  Shilpa Das; Muralidhar Ramappa; Ashik Mohamed; Sunita Chaurasia; Savitri Sharma; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.